208 related articles for article (PubMed ID: 29286604)
21. Increased phosphorylation on residue S795 of the retinoblastoma protein in esophageal adenocarcinoma.
Davelaar AL; Straub D; Parikh KB; Lau L; Fockens P; Krishnadath KK
Int J Oncol; 2015 Aug; 47(2):583-91. PubMed ID: 26058606
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic adenocarcinoma protein-protein interaction network analysis.
Rezaei-Tavirani M; Rezaei-Tavirani S; Ahmadi N; Naderi N; Abdi S
Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S85-S92. PubMed ID: 29511477
[TBL] [Abstract][Full Text] [Related]
23. Profiles of autophagy-related genes in esophageal adenocarcinoma.
Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
[TBL] [Abstract][Full Text] [Related]
24. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma.
Li Z; Yao Q; Zhao S; Wang Z; Li Y
Artif Intell Med; 2017 Feb; 76():1-6. PubMed ID: 28363284
[TBL] [Abstract][Full Text] [Related]
25. Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Zhang C; Sun Q
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):319-325. PubMed ID: 28585144
[TBL] [Abstract][Full Text] [Related]
26. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.
Ong CA; Shapiro J; Nason KS; Davison JM; Liu X; Ross-Innes C; O'Donovan M; Dinjens WN; Biermann K; Shannon N; Worster S; Schulz LK; Luketich JD; Wijnhoven BP; Hardwick RH; Fitzgerald RC
J Clin Oncol; 2013 Apr; 31(12):1576-82. PubMed ID: 23509313
[TBL] [Abstract][Full Text] [Related]
27. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
[TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
Lynam-Lennon N; Heavey S; Sommerville G; Bibby BA; Ffrench B; Quinn J; Gasch C; O'Leary JJ; Gallagher MF; Reynolds JV; Maher SG
Oncotarget; 2017 Feb; 8(7):11400-11413. PubMed ID: 28002789
[TBL] [Abstract][Full Text] [Related]
30. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
32. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
[TBL] [Abstract][Full Text] [Related]
33. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
Grady WM; Yu M
Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
[TBL] [Abstract][Full Text] [Related]
34. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
35. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
36. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
[TBL] [Abstract][Full Text] [Related]
37. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
Guo X; Tang Y; Zhu W
BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
[TBL] [Abstract][Full Text] [Related]
38. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
39. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
40. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
